FY2025 · period end Dec '25 · from the 10-K filed Feb 28, 2026
Data as filed with the SEC, provided for information only — not investment advice.
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $12.39B | $9.65B | $7.96B | $7.25B | $5.63B |
| Gross Profit | $1.49B | $1.03B | $0.78B | $0.64B | $0.49B |
| Operating Income | $1.04B | $0.60B | $0.38B | $0.26B | $0.17B |
| Net Income | $0.83B | $0.43B | $0.24B | $0.18B | — |
| EPS (Diluted) | $7.16 | $3.61 | $2.03 | $1.18 | $0.82 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $7.21B | $5.99B | $5.89B | $5.63B | $4.67B |
| Total Liabilities | $5.00B | $4.09B | $4.12B | $3.95B | $3.20B |
| Stockholders' Equity | $2.22B | $1.90B | $1.77B | $1.68B | $1.46B |
| Cash & Equivalents | $0.60B | $0.42B | $0.37B | $0.37B | $0.39B |
| Total Debt | $0.75B | $0.80B | $0.68B | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.66B | $0.47B | $0.43B | $0.30B | $0.23B |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 12.1% | 10.7% | 9.8% | 8.8% | 8.6% |
| Operating Margin | 0.1% | 0.1% | 0.0% | 0.0% | 3.0% |
| Net Margin | 0.1% | 0.0% | 0.1% | 0.1% | — |
| Return on Equity | 40.5% | 23.3% | 33.2% | 28.5% | — |
| Return on Assets | 12.6% | 7.2% | 9.9% | 8.7% | — |
| Debt / Equity | 0.35× | 0.42× | 0.38× | — | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or full history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001104659-26-107079 | Sep 11, 2026 | Sep 11, 2026 | Sep 12, 2026 00:22 UTC | EDGAR |
| 8-K | 0001104659-26-092676 | Aug 5, 2026 | Aug 7, 2026 | Aug 8, 2026 00:01 UTC | EDGAR |
| 8-K | 0001030894-26-000043 | Jul 27, 2026 | Jul 27, 2026 | Jul 28, 2026 00:44 UTC | EDGAR |
| 10-Q | 0001030894-26-000044 | Jun 30, 2026 | Jul 27, 2026 | Jul 28, 2026 00:47 UTC | EDGAR |
| 8-K | 0001030894-26-000038 | Jul 6, 2026 | Jul 6, 2026 | Jul 7, 2026 00:29 UTC | EDGAR |
| 8-K | 0001030894-26-000035 | May 19, 2026 | May 19, 2026 | May 20, 2026 00:21 UTC | EDGAR |
| 8-K | 0001104659-26-049818 | Apr 27, 2026 | Apr 28, 2026 | Apr 28, 2026 16:02 UTC | EDGAR |
| 8-K | 0001030894-26-000030 | Apr 27, 2026 | Apr 27, 2026 | Apr 28, 2026 00:23 UTC | EDGAR |
Direct links to SEC EDGAR. CLS has additional filings available on the SEC site.
6 numbers CELESTICA INC later changed — same XBRL tag, both filings linked.
StockholdersEquity·As of Dec 31, 2015
Minor restatementwas$1.1B
Revised up in a 20-F.
StockholdersEquity·As of Dec 31, 2016
Minor restatementwas$1.2B
Revised up in a 20-F.
NetIncomeToCommon·FY 2016
Minor restatementwas$136.3M
Revised up in a 20-F.
StockholdersEquity·As of Dec 31, 2017
Minor restatementwas$1.4B
Revised up in a 20-F.
StockholdersEquity·As of Dec 31, 2017
Minor restatementwas$1.4B
Revised up in a 20-F.
OperatingIncome·FY 2016
Minor restatementwas$156.7M
Revised up in a 20-F.
CLS is not the only one.
See every restatement we've found across the market — or get an alert the next time CLS revises a number.
Restatements are detected by comparing every vintage of a fact across all of CELESTICA INC's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows CLS's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling CELESTICA INC — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on CLS yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on CLS and publish the result to your public profile.
Ask about CELESTICA INC
Continue in Workspace — cited answers on CLS, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate, with delisted companies kept in.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs